Abbott Laboratories ABT has witnessed strong momentum in the past year. Shares of the company have risen 12.7% compared with the 9% growth of the industry during the same time frame. The S&P 500 ...

Abbott Laboratories closed 10.57% short of its 52-week high of $141.23, which the company reached on March 4th.

The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Today, Benzinga 's options scanner spotted 10 uncommon options trades for Abbott Laboratories. This isn't normal. The overall ...

Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...

Abbott EVP Lisa Earnhardt's pay increased 19% to $6.6 million as her medical device group's sales grew by 12%.

Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that ...

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

As for earnings, ABT’s fourth-quarter fiscal 2024 earnings report showed sales growth of 9.5% for the year (excluding COVID ...

Abbott, a manufacturer of diagnostics and medical devices, sent a film crew to highlight Auburn Community Hospital's ...